GANNON NYQUIST: Open Payments
NPI 1134793169 · VALLEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168 in 6 payments from 6 companies in 2025. Trend: 2023 $34 · 2024 $182 · 2025 $168
Food & beverage: $168
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $61 |
| GlaxoSmithKline, LLC. | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Madrigal Pharmaceuticals | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| JAZZ PHARMACEUTICALS INC. | 1 | $17 |
Products named: GLASSIA, NUCALA, DUPIXENT, REZDIFFRA, XYWAV.
Industry payments across CA — which companies pay providers there.
